Cancer Research Cancer Epigenetics Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 53, 2087-2091, May 1, 1993]
© 1993 American Association for Cancer Research
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davies, B.
Right arrow Articles by Balkwill, F. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davies, B.
Right arrow Articles by Balkwill, F. R.

A Synthetic Matrix Metalloproteinase Inhibitor Decreases Tumor Burden and Prolongs Survival of Mice Bearing Human Ovarian Carcinoma Xenografts

Bernard Davies, Peter D. Brown, Nick East, Michael J. Crimmin and Frances R. Balkwill1

Biological Therapy Laboratory, Imperial Cancer Research Fund, Lincoln's Inn Fields, London WC2A 3PX [B. D., F. R. B.]; British Biotechnology PLC, Cowley, Oxford OX4 5LY [P. D. B., M. J. C.]; and Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hertfordshire EN6 3LD [N. E.], England

We have examined the effect of a synthetic low-molecular-weight matrix metalloproteinase inhibitor, [4-(N-hydroxyamino)-2R-isobutyl-3S-(thiopen-2-ylthiomethy

l)-succinyl]-L-phenylalanine-N-methylamide (BB-94), on human ovarian carcinoma xenografts growing in nude mice. The xenografts grew as thick intraperitoneal mucinous ascites containing free-floating tumor cell clumps. The ascites increased in volume, causing death approximately 3 weeks after introduction. Treatment with BB-94 caused resolution of ascitic disease. Tumor burden was dramatically reduced, and survival increased 5-6-fold. The increase in survival was dose dependent. The effects observed with BB-94 appeared to be due to its matrix metalloproteinase inhibiting effects, inasmuch as its inactive diastereoisomer had no effect on tumor biology. Following treatment with BB-94, free-floating clumps of tumor cells became surrounded by a capsule of host cells. These clumps of tumor cells typically formed one small (approximately 8 mm) avascular tumor of bright white appearance loosely attached to fat in the peritoneum. Tumor cells within these capsules often appeared to be necrotic. Gel substrate analysis demonstrated that activated Mr 92,000 type IV collagenase was present in the xenografts. We propose that inhibition of this enzyme causes the transition of ascites to solid tumors, concomitantly slowing tumor cell growth and allowing the development of tumor stroma.

1 To whom requests for reprints should be addressed, at Imperial Cancer Research Fund, P. O. Box 123, Lincoln's Inn Fields, London WC2A 3PX, England.

Received 11/13/92. Accepted 2/25/93.




This article has been cited by other articles:


Home page
 Mol Cancer ResHome page
D. Belotti, C. Calcagno, A. Garofalo, D. Caronia, E. Riccardi, R. Giavazzi, and G. Taraboletti
Vascular Endothelial Growth Factor Stimulates Organ-Specific Host Matrix Metalloproteinase-9 Expression and Ovarian Cancer Invasion
Mol. Cancer Res., April 1, 2008; 6(4): 525 - 534.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Y. Zhou, Y. L. Pon, and A. S. T. Wong
Synergistic Effects of Epidermal Growth Factor and Hepatocyte Growth Factor on Human Ovarian Cancer Cell Invasion and Migration: Role of Extracellular Signal-Regulated Kinase 1/2 and p38 Mitogen-Activated Protein Kinase
Endocrinology, November 1, 2007; 148(11): 5195 - 5208.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. W.T. Cheung, P. C.K. Leung, and A. S.T. Wong
Gonadotropin-Releasing Hormone Promotes Ovarian Cancer Cell Invasiveness through c-Jun NH2-Terminal Kinase-Mediated Activation of Matrix Metalloproteinase (MMP)-2 and MMP-9.
Cancer Res., November 15, 2006; 66(22): 10902 - 10910.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
K. S. Moshal, U. Sen, N. Tyagi, B. Henderson, M. Steed, A. V. Ovechkin, and S. C. Tyagi
Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway
Am J Physiol Cell Physiol, March 1, 2006; 290(3): C883 - C891.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
T. J. Kaitu'u, J. Shen, J. Zhang, N. B. Morison, and L. A. Salamonsen
Matrix Metalloproteinases in Endometrial Breakdown and Repair: Functional Significance in a Mouse Model
Biol Reprod, October 1, 2005; 73(4): 672 - 680.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
O. D. Defawe, R. D. Kenagy, C. Choi, S. Y.C. Wan, C. Deroanne, B. Nusgens, N. Sakalihasan, A. Colige, and A. W. Clowes
MMP-9 regulates both positively and negatively collagen gel contraction: A nonproteolytic function of MMP-9
Cardiovasc Res, May 1, 2005; 66(2): 402 - 409.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. M. Lee, B.-J. Yoon, K. Osiewicz, M. Preston, B. Bundy, A. M. van Heeckeren, Z. Werb, and P. D. Soloway
Tissue Inhibitor of Metalloproteinase 1 Regulates Resistance to Infection
Infect. Immun., January 1, 2005; 73(1): 661 - 665.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
M. Mazzone, M. Baldassarre, G. Beznoussenko, G. Giacchetti, J. Cao, S. Zucker, A. Luini, and R. Buccione
Intracellular processing and activation of membrane type 1 matrix metalloprotease depends on its partitioning into lipid domains
J. Cell Sci., December 15, 2004; 117(26): 6275 - 6287.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Hallermalm, A. De Geer, R. Kiessling, V. Levitsky, and J. Levitskaya
Autocrine Secretion of Fas Ligand Shields Tumor Cells from Fas-Mediated Killing by Cytotoxic Lymphocytes
Cancer Res., September 15, 2004; 64(18): 6775 - 6782.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W.-H. Yoon, Y.-J. Jung, T.-D. Kim, G. Li, B.-J. Park, J.-Y. Kim, Y.-C. Lee, J.-M. Kim, J.-I. Park, H.-D. Park, et al.
Gabexate Mesilate Inhibits Colon Cancer Growth, Invasion, and Metastasis by Reducing Matrix Metalloproteinases and Angiogenesis
Clin. Cancer Res., July 1, 2004; 10(13): 4517 - 4526.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. L. Fowlkes, D. M. Serra, R. C. Bunn, K. M. Thrailkill, J. J. Enghild, and H. Nagase
Regulation of Insulin-Like Growth Factor (IGF)-I Action by Matrix Metalloproteinase-3 Involves Selective Disruption of IGF-I/IGF-Binding Protein-3 Complexes
Endocrinology, February 1, 2004; 145(2): 620 - 626.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Trexler, K. Briknarova, M. Gehrmann, M. Llinas, and L. Patthy
Peptide Ligands for the Fibronectin Type II Modules of Matrix Metalloproteinase 2 (MMP-2)
J. Biol. Chem., March 28, 2003; 278(14): 12241 - 12246.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. T. Daniels, A. D. Cambrey, N. L. Occleston, Q. Garrett, R. W. Tarnuzzer, G. S. Schultz, and P. T. Khaw
Matrix Metalloproteinase Inhibition Modulates Fibroblast-Mediated Matrix Contraction and Collagen Production In Vitro
Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1104 - 1110.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
M. Baldassarre, A. Pompeo, G. Beznoussenko, C. Castaldi, S. Cortellino, M. A. McNiven, A. Luini, and R. Buccione
Dynamin Participates in Focal Extracellular Matrix Degradation by Invasive Cells
Mol. Biol. Cell, March 1, 2003; 14(3): 1074 - 1084.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. E. K. Russell, A. Thorley, S. V. Culpitt, S. Dodd, L. E. Donnelly, C. Demattos, M. Fitzgerald, and P. J. Barnes
Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases
Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L867 - L873.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Avramovich, T. Amit, and M. B. H. Youdim
Non-steroidal Anti-inflammatory Drugs Stimulate Secretion of Non-amyloidogenic Precursor Protein
J. Biol. Chem., August 23, 2002; 277(35): 31466 - 31473.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
L. A. Liotta and E. C. Kohn
Stromal Therapy: The Next Step in Ovarian Cancer Treatment
J Natl Cancer Inst, August 7, 2002; 94(15): 1113 - 1114.
[Full Text] [PDF]

Home page
 JCOHome page
M. Cianfrocca, T. P. Cooley, J. Y. Lee, M. A. Rudek, D. T. Scadden, L. Ratner, J. M. Pluda, W. D. Figg, S. E. Krown, and B. J. Dezube
Matrix Metalloproteinase Inhibitor COL-3 in the Treatment of AIDS-Related Kaposi's Sarcoma: A Phase I AIDS Malignancy Consortium Study
J. Clin. Oncol., January 1, 2002; 20(1): 153 - 159.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. A. Karsdal, M. S. Fjording, N. T. Foged, J.-M. Delaisse, and A. Lochter
Transforming Growth Factor-beta -induced Osteoblast Elongation Regulates Osteoclastic Bone Resorption through a p38 Mitogen-activated Protein Kinase- and Matrix Metalloproteinase-dependent Pathway
J. Biol. Chem., October 12, 2001; 276(42): 39350 - 39358.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
R. Hoekstra, F.A.L.M. Eskens, and J. Verweij
Matrix Metalloproteinase Inhibitors: Current Developments and Future Perspectives
Oncologist, October 1, 2001; 6(5): 415 - 427.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. R. Bramhall, A. Rosemurgy, P. D. Brown, C. Bowry, and J. A.C. Buckels
Marimastat as First-Line Therapy for Patients With Unresectable Pancreatic Cancer: A Randomized Trial
J. Clin. Oncol., August 1, 2001; 19(15): 3447 - 3455.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Aznavoorian, B. A. Moore, L. D. Alexander-Lister, S. L. Hallit, L. J. Windsor, and J. A. Engler
Membrane Type I-Matrix Metalloproteinase-Mediated Degradation of Type I Collagen by Oral Squamous Cell Carcinoma Cells
Cancer Res., August 1, 2001; 61(16): 6264 - 6275.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. A. Fishman, Y. Liu, S. M. Ellerbroek, and M. S. Stack
Lysophosphatidic Acid Promotes Matrix Metalloproteinase (MMP) Activation and MMP-dependent Invasion in Ovarian Cancer Cells
Cancer Res., April 1, 2001; 61(7): 3194 - 3199.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
M. Hidalgo and S. G. Eckhardt
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
J Natl Cancer Inst, February 7, 2001; 93(3): 178 - 193.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
I. Kazes, I. Elalamy, J.-D. Sraer, M. Hatmi, and G. Nguyen
Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation
Blood, November 1, 2000; 96(9): 3064 - 3069.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P.-P. H. Lee, J.-J. Hwang, G. Murphy, and M. M. Ip
Functional Significance of MMP-9 in Tumor Necrosis Factor-Induced Proliferation and Branching Morphogenesis of Mammary Epithelial Cells
Endocrinology, October 1, 2000; 141(10): 3764 - 3773.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. W. Griffioen and G. Molema
Angiogenesis: Potentials for Pharmacologic Intervention in the Treatment of Cancer, Cardiovascular Diseases, and Chronic Inflammation
Pharmacol. Rev., June 1, 2000; 52(2): 237 - 268.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. A. Bunn Jr., A. Soriano, G. Johnson, and L. Heasley
New Therapeutic Strategies for Lung Cancer : Biology and Molecular Biology Come of Age
Chest, April 1, 2000; 117 (2009): 163S - 168S.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. R. Nelson, B. Fingleton, M. L. Rothenberg, and L. M. Matrisian
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
J. Clin. Oncol., March 1, 2000; 18(5): 1135 - 1135.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
D. P. Mason, R. D. Kenagy, D. Hasenstab, D. F. Bowen-Pope, R. A. Seifert, S. Coats, S. M. Hawkins, and A. W. Clowes
Matrix Metalloproteinase-9 Overexpression Enhances Vascular Smooth Muscle Cell Migration and Alters Remodeling in the Injured Rat Carotid Artery
Circ. Res., December 3, 1999; 85(12): 1179 - 1185.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
N. Mitsiades, V. Poulaki, A. Leone, and M. Tsokos
Fas-Mediated Apoptosis in Ewing's Sarcoma Cell Lines by Metalloproteinase Inhibitors
J Natl Cancer Inst, October 6, 1999; 91(19): 1678 - 1684.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. Aparicio, S. Kermorgant, V. Dessirier, M. J.M. Lewin, and T. Lehy
Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats
Carcinogenesis, August 1, 1999; 20(8): 1445 - 1452.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. Mira, S. Mañes, R. A. Lacalle, G. Márquez, and C. Martínez-A
Insulin-Like Growth Factor I-Triggered Cell Migration and Invasion Are Mediated by Matrix Metalloproteinase-9
Endocrinology, April 1, 1999; 140(4): 1657 - 1664.
[Abstract] [Full Text]

Home page
 Arch OphthalmolHome page
A. Das, A. McLamore, W. Song, and P. G. McGuire
Retinal Neovascularization Is Suppressed With a Matrix Metalloproteinase Inhibitor
Arch Ophthalmol, April 1, 1999; 117(4): 498 - 503.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Price, Q. Shi, D. Morris, M. E. Wilcox, P. M. A. Brasher, N. B. Rewcastle, D. Shalinsky, H. Zou, K. Appelt, R. N. Johnston, et al.
Marked Inhibition of Tumor Growth in a Malignant Glioma Tumor Model by a Novel Synthetic Matrix MetalloproteinaseInhibitor AG3340
Clin. Cancer Res., April 1, 1999; 5(4): 845 - 854.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
V. M. Macaulay, K. J. O'Byrne, M. P. Saunders, J. P. Braybrooke, L. Long, F. Gleeson, C. S. Mason, A. L. Harris, P. Brown, and D. C. Talbot
Phase I Study of Intrapleural Batimastat (BB-94), a Matrix Metalloproteinase Inhibitor, in the Treatment of Malignant Pleural Effusions
Clin. Cancer Res., March 1, 1999; 5(3): 513 - 520.
[Abstract] [Full Text] [PDF]

Home page
 ADRHome page
B.L. Lokeshwar, H.L. Houston-Clark, M.G. Selzer, N.L. Block, and L.M. Golub
Potential Application of a Chemically Modified Non-Antimicrobial Tetracycline (CMT-3) Against Metastatic Prostate Cancer
Advances in Dental Research, November 1, 1998; 12(1): 97 - 102.
[PDF]

Home page
 StrokeHome page
G. A. Rosenberg, E. Y. Estrada, J. E. Dencoff, and C. Y. Hsu
Matrix Metalloproteinases and TIMPs Are Associated With Blood-Brain Barrier Opening After Reperfusion in Rat Brain • Editorial Comment
Stroke, October 1, 1998; 29(10): 2189 - 2195.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. L. Brown, K. S. Meise, G. D. Plowman, R. J. Coffey, and P. J. Dempsey
Cell Surface Ectodomain Cleavage of Human Amphiregulin Precursor Is Sensitive to a Metalloprotease Inhibitor. RELEASE OF A PREDOMINANT N-GLYCOSYLATED 43-kDa SOLUBLE FORM
J. Biol. Chem., July 3, 1998; 273(27): 17258 - 17268.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. P. Kitson, P. M. Appasamy, U. Nannmark, P. Albertsson, M. K. Gabauer, and R. H. Goldfarb
Matrix Metalloproteinases Produced by Rat IL-2-Activated NK Cells
J. Immunol., May 1, 1998; 160(9): 4248 - 4253.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. P. Mari, I. C. Anderson, S. E. Mari, Y. Ning, Y. Lutz, L. Kobzik, and M. A. Shipp
Stromelysin-3 Is Induced in Tumor/Stroma Cocultures and Inactivated via a Tumor-specific and Basic Fibroblast Growth Factor-dependent Mechanism
J. Biol. Chem., January 2, 1998; 273(1): 618 - 626.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
P. J. Dempsey, K. S. Meise, Y. Yoshitake, K. Nishikawa, and R. J. Coffey
Apical Enrichment of Human EGF Precursor in Madin-Darby Canine Kidney Cells Involves Preferential Basolateral Ectodomain Cleavage Sensitive to a Metalloprotease Inhibitor
J. Cell Biol., August 25, 1997; 138(4): 747 - 758.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R.D. Kenagy, S. Vergel, E. Mattsson, M. Bendeck, M.A. Reidy, and A.W. Clowes
The Role of Plasminogen, Plasminogen Activators, and Matrix Metalloproteinases in Primate Arterial Smooth Muscle Cell Migration
Arterioscler Thromb Vasc Biol, November 1, 1996; 16(11): 1373 - 1382.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
D. Pei and S. J. Weiss
Transmembrane-deletion Mutants of the Membrane-type Matrix Metalloproteinase-1 Process Progelatinase A and Express Intrinsic Matrix-degrading Activity
J. Biol. Chem., April 12, 1996; 271(15): 9135 - 9140.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
C. Alexander, E. Hansell, O Behrendtsen, M. Flannery, N. Kishnani, S. Hawkes, and Z Werb
Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation
Development, January 6, 1996; 122(6): 1723 - 1736.
[Abstract] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
N. Zempo, N. Koyama, R. D. Kenagy, H. J. Lea, and A. W. Clowes
Regulation of Vascular Smooth Muscle Cell Migration and Proliferation In Vitro and in Injured Rat Arteries by a Synthetic Matrix Metalloproteinase Inhibitor
Arterioscler Thromb Vasc Biol, January 1, 1996; 16(1): 28 - 33.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
M. R. Gehring, B. Condon, S. A. Margosiak, and C.-C. Kan
Characterization of the Phe-81 and Val-82 Human Fibroblast Collagenase Catalytic Domain Purified from Escherichia coli
J. Biol. Chem., September 22, 1995; 270(38): 22507 - 22513.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. L. Brown, R. J. Coffey, and P. J. Dempsey
The Proamphiregulin Cytoplasmic Domain Is Required for Basolateral Sorting, but Is Not Essential for Constitutive or Stimulus-induced Processing in Polarized Madin-Darby Canine Kidney Cells
J. Biol. Chem., July 27, 2001; 276(31): 29538 - 29549.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.